ACUTE MYELOID LEUKEMIA IN REMISSION
Clinical trials for ACUTE MYELOID LEUKEMIA IN REMISSION explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA IN REMISSION trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA IN REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a gentler drug schedule keep leukemia at bay?
Disease control Recruiting nowThis study is testing if a shorter, 14-day cycle of the drug venetoclax is easier for patients to tolerate while still keeping their acute myeloid leukemia (AML) in remission. It is for 41 adults with AML who are in remission but cannot receive intensive treatments like stem cell…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo aims to boost survival in leukemia transplant patients
Disease control Recruiting nowThis study is testing which of two drug combinations works better to prepare adults with acute myeloid leukemia (AML) for a stem cell transplant. The goal is to see if using clofarabine instead of fludarabine before the transplant helps patients live longer by reducing the chance…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug trial aims to stop blood Cancer's comeback after transplant
Disease control Recruiting nowThis early-stage study is testing whether adding an experimental drug called ziftomenib to standard care after a bone marrow transplant is safe and can help keep acute myeloid leukemia (AML) from coming back. The study will enroll about 22 adults with specific genetic types of AM…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Targeted radiation zaps blood cancer cells before transplant
Disease control Recruiting nowThis study is testing a new treatment for aggressive blood cancers (like leukemia or MDS) that have come back or are not responding to standard therapies. The treatment involves a radioactive antibody designed to seek out and destroy cancer cells, followed by a stem cell transpla…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC